Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
N/A
54,052 Added 415.5%
67,061 $46,000
Q4 2023

Feb 14, 2024

SELL
N/A
-133,792 Reduced 91.14%
13,009 $8,000
Q3 2023

Nov 14, 2023

BUY
N/A
134,582 Added 1101.42%
146,801 $101,000
Q2 2023

Aug 14, 2023

BUY
$0.0 - $0.69 $0 - $8,431
12,219 New
12,219 $8,000
Q4 2022

Feb 14, 2023

BUY
$0.24 - $0.4 $11,864 - $19,774
49,436 New
49,436 $11,000
Q2 2022

Aug 16, 2022

BUY
$0.26 - $0.37 $2,273 - $3,234
8,743 Added 72.67%
20,774 $6,000
Q1 2022

May 17, 2022

SELL
$0.31 - $0.41 $9,397 - $12,429
-30,316 Reduced 71.59%
12,031 $4,000
Q4 2021

Feb 15, 2022

BUY
$0.38 - $0.68 $16,091 - $28,795
42,347 New
42,347 $16,000
Q1 2021

May 18, 2021

SELL
$0.53 - $2.47 $13,103 - $61,068
-24,724 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$0.36 - $0.58 $8,900 - $14,339
24,724 New
24,724 $11,000

Others Institutions Holding ISR

About Isoray, Inc.


  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.